Table 2.

Investigator-assessed objective response rates

Response, % (95% CI)	Best overall response (n = 40)	Overall response at primary response assessment (n = 40)
Overall response	95.0 (83.1-99.4)	87.5 (73.2-95.8)
CR	90.0 (76.3-97.2)	85.0 (70.2-94.3)
PR	5.0 (0.6-16.9)	2.5 (0.1-13.2)
Stable disease	0 (0-8.8)	0 (0-8.8)
PD	0 (0-8.8)	7.5 (1.6-20.4)
Data missing∗, %	5.0	5.0

CR, complete response; PR, partial response; PD, progressive disease

^∗Two patients discontinued study treatment before having any response assessment performed.